Antibody Contract Manufacturing Market Research Report, Growth and Forecast
According to Rohan Patil, who specializes in biotechnology and pharmaceutical market research, with 5+ years of experience in market research and industry analysis. His research reveals that the antibody contract manufacturing market is projected to grow from USD 20.4 billion in 2026 to USD 46.94 billion by 2035, driven by biologics demand, outsourcing trends, and technological advancements. The analysis covers key segments including service type, antibody type, expression systems, and scale of operation, while highlighting North America’s leadership, Asia Pacific’s rapid growth, and the competitive landscape featuring major companies such as Lonza Group, Samsung Biologics, WuXi Biologics, and Thermo Fisher Scientific.
Last Updated : 14 July 2026
Category: Biotechnology
Insight Code: 6869
Format: PDF / PPT / Excel